DIP Episode 52 - Comprehensive USMLE Step 1 Renal Review (Session 1 of 3)

Source / episode info

• Episode: 52
• Title: Divine Intervention Episode 52 – Comprehensive USMLE Step 1 Renal Review (Session 1 of 3)
• Published: 2018-09-27
• Source: Episode page

One-liner

This episode provides a comprehensive review of renal physiology, covering the detailed mechanisms of tubular reabsorption (PCT/DCT), acid-base balance disorders (RTA), diuretic pharmacology, differentiating types of acute kidney injury (AKI), and key associations in UT Is and endocrine nephrology.

High-yield summary

• SGLT2 Inhibitors: These drugs (e.g., canagliflozin) inhibit the {Na}^+-glucose co-transporter in the proximal convoluted tubule, leading to glucosuria. They are associated with UT Is and metabolic acidosis.
• Pyelonephritis Workup: Flank pain + dysuria + fever suggests pyelonephritis (vs. suprapubic pain of cystitis). Classic UTI pathogens include Proteus mirabilis (swarming motility) and Staphylococcus saprophyticus.
• AKI Differentiation: Post-renal AKI (e.g., BPH obstruction) is characterized by {BUN}/{Cr} < 15, {Urine Na}^+ > 40 { mEq/L}, {FeNa} > 2\%, and low urine osmolality (<350 { mOsm/kg}). ATN shows muddy brown casts.
• Electrolyte Management: Hyperkalemia (e.g., rhabdomyolysis) is treated by stabilizing the myocardium ({Ca}^{2+}), shifting {K}^+ intracellularly (Insulin + Glucose, _2-agonists), or removing it (diuretics, cation-exchange resins).
• Diuretic Effects: Loop diuretics are the most potent and cause significant {K}^+ wasting. Thiazides are preferred for preventing calcium nephrolithiasis because they increase urinary calcium excretion.

Learning objectives

• Differentiate the pathophysiology of various types of metabolic acidosis (e.g., Type 2 RTA vs. carbonic anhydrase inhibitor use).
• Analyze urinary indices (\text{FeNa}, \text{Urine Na}^+, \text{BUN}/\text{Cr}) to classify the cause of acute kidney injury (AKI).
• Correlate drug mechanisms (e.g., thiazides, loop diuretics) with specific electrolyte disturbances and nephrolithiasis risk.
• Recognize classic physical exam findings associated with hypocalcemia (Trousseau's/Chvostek's signs) and hyperkalemia (peaked T waves).
• Understand the hormonal regulation of renal function, particularly the roles of PTH, RAAS, and \text{ADH}.

Board exam buzzwords

Rapid review table

Board-speak -> diagnosis

Differential diagnosis / distinguishing features

Metabolic Acidosis

Urinary Tract Infections (UT Is)

Management pearls

• For suspected urinary obstruction/AKI, perform a bladder scan and ultrasound to rule out mechanical causes (e.g., BPH). Foley catheterization is indicated for post-renal AKI workup.
• In the setting of severe hypocalcemia, administer IV calcium gluconate or calcium chloride immediately to stabilize the myocardium, followed by definitive management (e.g., Vitamin D/PTH replacement).
• When treating hyperkalemia due to rhabdomyolysis, always give Insulin + Glucose and consider \text{Ca}^{2+} stabilization first.
• For suspected pyelonephritis in a diabetic patient, be highly suspicious of SGLT2 inhibitor-associated UT Is.

Don't miss

Integration & clinical reasoning

• Acid-Base/Electrolytes: The combination of hypokalemia and metabolic acidosis (e.g., from carbonic anhydrase inhibitors) is unique because typically hypokalemia accompanies metabolic alkalosis due to volume contraction/RAAS activation.
• Nephrology/Endocrinology: PTH acts on the kidney in two ways: increasing phosphate excretion via PCT endocytosis, and promoting calcium reabsorption at the DCT (via increased \text{Ca}^{2+} transporter activity).
• Pharmacology/Renal Function: Thiazide diuretics are excellent for preventing calcium nephrolithiasis because they increase urinary calcium excretion by enhancing paracellular \text{Ca}^{2+} reabsorption.

OMM / COMLEX integration

• Acute/Unstable Management Priority: In any setting of suspected acute kidney injury (e.g., rhabdomyolysis or severe volume depletion), standard emergency management (IV fluids, \text{Ca}^{2+} stabilization, insulin) takes absolute priority over OMT protocols.
• Electrolyte Monitoring: When administering nephrotoxic agents (e.g., aminoglycosides), continuous monitoring of electrolytes (\text{K}^+, \text{Mg}^{2+}, \text{Phosphate}) is critical due to the risk of acute tubular necrosis and subsequent electrolyte derangements.

Concept connections / cross-references

• For detailed review of the RAAS system and its components, see [Episode 37].
• The mechanism of PTH action on phosphate transport is related to general renal tubular handling discussed in [Episode 45].
• Understanding the difference between primary vs secondary adrenal insufficiency (AI) physiology was covered in [Episode 21].

High-yield association table

Key terms glossary

Study optimization

Question pattern recognition

• The "Best Answer" Trap: Questions often test the most specific or least common finding (e.g., \text{ROMK} channel in TAL, or the difference between pyelonephritis vs cystitis pain).
• Differential Diagnosis by Indices: Expect questions that require you to calculate/compare urinary indices (\text{FeNa}, \text{BUN}/\text{Cr}) to classify AKI.
• Mechanism of Action (MOA) Linkage: Linking a drug's MOA (e.g., thiazide blocking DCT transporter) directly to its clinical effect (e.g., increased urinary calcium excretion).

Test yourself

Common mistakes to avoid

Common traps